EuroQol 5-Dimension Questionnaire in Heart Failure With Reduced, Mildly Reduced, and Preserved Ejection Fraction

The EQ-5D revealed problems not often associated (eg, pain) with HF or commonly quantified in HF (eg, anxiety/depression). Dapagliflozin improved multiple QoL dimensions, and possibly anxiety/depression. (Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure [DAPA-HF]; NCT03036124; Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure [DELIVER]; NCT03619213).

Authors

Institutions

Publication Details

Journal
JACC Heart Failure
Published
2025-02-01
DOI
https://doi.org/10.1016/j.jchf.2024.10.020
Citations
9
Primary Topic
Cardiovascular Function and Risk Factors
Type
article
Field-Weighted Citation Impact
12.49
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EuroQol 5-Dimension Questionnaire in Heart Failure With Reduced, Mildly Reduced, and Preserved Ejection Fraction

Kieran F. Docherty, Brian Lee Claggett, Adrian F. Hernandez, Piotr Ponikowski et al.
9 citations
JACC Heart Failure
Cardiovascular Function and Risk Factors
12.49
article

EuroQol 5-Dimension Questionnaire in Heart Failure With Reduced, Mildly Reduced, and Preserved Ejection Fraction

Kieran F. Docherty, Brian Lee Claggett, Adrian F. Hernandez, Piotr Ponikowski, Pardeep S. Jhund, John J.V. McMurray, Marc S. Sabatine, Rudolf A. de Boer, Lars Køber, Felipe A. Martínez, Atefeh Talebi, Erasmus Bachus, Mikhail Kosiborod, Scott David Solomon, Muthiah Vaduganathan, Carolyn S.P. Lam, Toru Kondo, Mingming Yang, Akshay S. Desai
article en
9 citations

Abstract

The EQ-5D revealed problems not often associated (eg, pain) with HF or commonly quantified in HF (eg, anxiety/depression). Dapagliflozin improved multiple QoL dimensions, and possibly anxiety/depression. (Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure [DAPA-HF]; NCT03036124; Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure [DELIVER]; NCT03619213).

JACC Heart FailureVol. 13(2)
Brigham and Women's Hospital (US), Harvard University (US), National University of Singapore (SG), Universidad Nacional de Córdoba (AR), Erasmus MC (NL), Copenhagen University Hospital (DK), Rigshospitalet (DK), British Heart Foundation (GB), Wroclaw Medical University (PL), Clinical Research Institute (US), National University Heart Centre Singapore (SG), Duke Medical Center (US), Saint Luke's Hospital (US), AstraZeneca (Sweden) (SE), National Heart Centre Singapore (SG), Thrombolysis in Myocardial Infarction Study Group (US), University of Missouri–Kansas City (US), University of Glasgow (GB)
Openalex Percentile: Top 1%
Cardiovascular Function and Risk Factors
12.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.